Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
This guide examines the two compounds from a scientific point of view, strictly for research purposes only
As of April 2026, CJC-1295 and Ipamorelin have been removed from the Food and Drug Administrations (FDA) Category 2 restricted list, with formal review of compounding eligibility scheduled for July 2026
Learn more about CJC-1295 DAC here, including the various formulations on offer from Direct Peptides
And while some research suggests growth hormone may have certain health benefits, there's very little evidence showing that CJC-1295 delivers the outcomes being promised, particularly for women in perimenopause and menopause
Good patient-centred decision making around the use of dietary supplements requires multidisciplinary care, involving oncologists, integrative medicine providers, clinical pharmacists, dietitians and nursing to monitor and mitigate risk as well as to fully document all supplement uses and be aware how they may interact with conventional therapy (239)
It is prepared in accordance with Section 503A of the Federal Food, Drug, and Cosmetic Act and is dispensed solely pursuant to a valid patient-specific prescription from a licensed healthcare provider
